SpectraScience, Inc. (OTC: SCIE) is a medical device company that creates, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that uses this technology for clinical use. For more information, visit the company’s website at www.spectrascience.com